# Keun‐Wook Lee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/keun-wook-lee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,303 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 56 |
| i10-index | 202 |
| Last Known Institution | Seoul National University Bundang Hospital |
| OpenAlex ID | https://openalex.org/A5084847095 |
| ORCID iD | https://orcid.org/0000-0002-8491-703X |
| Works | 507 |

## Researcher papers

- [Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project](https://scholariq.org/papers/clinical-significance-of-four-molecular-subtypes-of-gastric-cancer-identified-by/)
- [Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial](https://scholariq.org/papers/modified-xeliri-capecitabine-plus-irinotecan-versus-folfiri-leucovorin/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Researcher university

- [Seoul National University Bundang Hospital](https://scholariq.org/institutions/seoul-national-university-bundang-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.